ADMA Biologics, Inc. (ADMA) NASDAQ
7.60
-0.3(-3.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.35B |
| Enterprise Value | 4.34B |
| P/E Ratio | 10.85 |
| PEG Ratio | -0.52 |
| Price/Sales Ratio | 3.45 |
| Price/Book Ratio | 4.6 |
| Enterprise/Revenue | 3.58 |
| Enterprise/EBITDA | 8.6 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.32 |
| Operating Margin | 0.41 |
Management Effectiveness
| Return On Assets | 0.25 |
| Return On Equity | 0.39 |
Income Statement
| Revenue | 510.17M |
| Revenue/Share | 2.16 |
| Gross Profit | 292.77M |
| EBITDA | 197.86M |
| Net Income | 146.93M |
| Diluted EPS | 0.6 |
Balance Sheet
| Total Cash | 138.15M |
| Total Cash/Share | 0.59 |
| Total Debt | 204.41M |
| Total Debt/Equity | 0.52 |
| Current Ratio | 6.95 |
| Book Value Per Share | 1.65 |
Price History
| 52-Week Change | -62.8 |
| 52-Week High | 22.37 |
| 52-Week Low | 7.21 |
| Moving Average 50 Days | 9.67 |
| Moving Average 200 Days | 14.91 |
Statistics
| Average Volume | 7.07M |
| Shares Outstanding | 231.77M |
| % Held by Institutions | 88.89 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
